Investing.com -- JPMorgan Chase & Co. (NYSE:JPM) has disclosed that its independent board members have approved a rise in annual compensation for CEO James Dimon. For the year 2024, Mr. Dimon will ...
Chairman and chief executive of J.P. Morgan Chase, James Dimon, told employees on Tuesday that he has been diagnosed with throat cancer but that the prognosis is excellent. (Photo: Getty Images) ...
Hosted on MSN1mon
JPMorgan stock hits all-time high at $266.82 amid robust growthIn other recent news, JPMorgan Chase & Co., under CEO James Dimon's leadership, has seen a rise in annual compensation, with the board approving a $39 million package for 2024, up from $36 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback